Product NDC: | 0378-6810 |
Proprietary Name: | Zaleplon |
Non Proprietary Name: | Zaleplon |
Active Ingredient(s): | 10 mg/1 & nbsp; Zaleplon |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-6810 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077238 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120501 |
Package NDC: | 0378-6810-10 |
Package Description: | 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-6810-10) |
NDC Code | 0378-6810-10 |
Proprietary Name | Zaleplon |
Package Description | 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-6810-10) |
Product NDC | 0378-6810 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Zaleplon |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20120501 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | ZALEPLON |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | gamma-Aminobutyric Acid A Receptor Agonist [EPC],GABA A Agonists [MoA],Central Nervous System Depression [PE] |